ישראל -
עברית -
Ministry of Health
אסטרוגנוס ® 0.3 מ"ג
salomon,levin & elstein ltd - estrogens conjugated 0.3 mg - tablets - conjugated estrogens - estrogenus tablets are indicated in the:1. treatment of moderate to severe vasomotor symptoms associated with menopause. 2. treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause. when prescribing solely for the treatment of moderate to severe vaginal dryness and pain with intercourse, topical vaginal products should be considered.
ישראל -
עברית -
Ministry of Health
אסטרוגנוס ® 0.45 מ"ג
salomon,levin & elstein ltd - estrogens conjugated 0.45 mg - tablets - conjugated estrogens - estrogenus tablets are indicated in the:treatment of moderate to severe vasomotor symptoms associated with menopause.
ישראל -
עברית -
Ministry of Health
אסטרוגנוס ® 0.625 מ"ג
salomon,levin & elstein ltd - estrogens conjugated 0.625 mg - tablets - conjugated estrogens - estrogenus tablets are indicated in the:treatment of moderate to severe vasomotor symptoms associated with menopause.
ישראל -
עברית -
Ministry of Health
אסטרוגנוס ® 0.9 מ"ג
salomon,levin & elstein ltd - estrogens conjugated 0.9 mg - tablets - conjugated estrogens - estrogenus tablets are indicated in the:treatment of moderate to severe vasomotor symptoms associated with menopause.
ישראל -
עברית -
Ministry of Health
אסטרוגנוס ® 1.25 מ"ג
salomon,levin & elstein ltd - estrogens conjugated 1.25 mg - tablets - conjugated estrogens - estrogenus tablets are indicated in the:treatment of moderate to severe vasomotor symptoms associated with menopause.
ישראל -
עברית -
Ministry of Health
לבופלוקסצין טבע ® 250 מ"ג
teva pharmaceutical indust.ltd - levofloxacin hemihydrate 250 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.